they lose their ability to produce erythropoietin as they transdifferentiate into myofibroblasts following kidney injury In anaemia associated with renal disease, erythropoiesis is suppressed due to the combined and interrelated effects of erythropoietin deficiency, inflammatory cytokines and iron deficiency The pharmacologic activation of hypoxia responses with HIF stabilizers provides a physiologic and comprehensive approach to the treatment of renal anaemia and warrants large, long-term clinical safety and efficacy trials Abstract Improved understanding of the oxygen-dependent regulation of erythropoiesis has provided new insights into the pathogenesis of anaemia associated with renal failure and has led to the development of novel therapeutic agents for its treatment
let air-dry 30 seconds
Reduces adiposity, sustains muscle function, and optimizes glucose metabolism
Interestingly, the latter of these two studies found that the drug was specifically effective in testing the memory function following a prolonged inter-trial interval, suggesting that it enhances long-term memory consolidation
It is not yet commercially available though appears to be in the market off-label
CAS Number: 68-19-9 (Cyanocobalamin reference form) Molecular Formula: C63H88CoN14O14P Molecular Weight: ~1355.38 g/mol Compound Classification: Naturally occurring cobalt-containing corrinoid vitamin Specifications Form: Aqueous solution Concentration: 1000 g/mL (nominal) Vitamin B-12 Volume: 10 mL Filtration: 0.2 m sterile membrane Preservative: 0.9% Benzyl Alcohol Container: Sterile glass vial Appearance: Red solution Purity: Manufactured to defined specification (98% assay cyanocobalamin
